Model Number 10623 |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problems
Death (1802); Heart Failure (2206)
|
Event Date 12/01/2020 |
Event Type
Death
|
Event Description
|
Synergy (b)(6) registry.It was reported that the patient died.In (b)(6) 2019, the subject was referred for cardiac catherization.The index procedure was performed and the subject was enrolled on the same day.The target lesion was located in the distal left circumflex artery (lcx) with 85% stenosis and was 35mm long with a reference vessel diameter of 2.75mm.The lesion treated with direct deployment of a 2.75mm x 38mm synergy stent system.Following post-dilatation the residual stenosis was 5%.Two weeks and four days later, the subject was discharged on aspirin and ticagrelor.In (b)(6) 2020, the subject experienced cardiac insufficiency and on an unknown date the subject expired with an unknown cause of death.No action was taken to treat the event and it is unknown if an autopsy was performed.No other additional information is available at this time of report.
|
|
Manufacturer Narrative
|
E1 initial reporter address 1: (b)(6).Correction: b3 event date: (b)(6) 2020, initially reported.And correct event date should have been (b)(6) 2020.No event date was provided.Therefore, the first date of the month of the aware date was used.
|
|
Event Description
|
Synergy china registry: it was reported, that the patient died.In (b)(6) 2019, the subject was referred for cardiac catherization.The index procedure was performed, and the subject was enrolled on the same day.The target lesion was located in the distal left circumflex artery (lcx) with 85% stenosis, and was 35mm long with a reference vessel diameter of 2.75mm.The lesion treated with direct deployment of a 2.75mm x 38mm synergy stent system.Following post-dilatation, the residual stenosis was 5%.Two weeks and four days later, the subject was discharged on aspirin and ticagrelor.In (b)(6) 2020, the subject experienced cardiac insufficiency.And on an unknown date, the subject expired with an unknown cause of death.No action was taken to treat the event.And it is unknown, if an autopsy was performed.No other additional information is available at this time of report.
|
|
Manufacturer Narrative
|
E1: initial reporter address 1: (b)(6).
|
|
Event Description
|
Synergy china registry.It was reported that the patient died.On (b)(6) 2019, the subject was referred for cardiac catherization.The index procedure was performed and the subject was enrolled on the same day.The target lesion was located in the distal left circumflex artery (lcx) with 85% stenosis and was 35mm long with a reference vessel diameter of 2.75mm.The lesion treated with direct deployment of a 2.75mm x 38mm synergy stent system.Following post-dilatation the residual stenosis was 5%.Two weeks and four days later, the subject was discharged on aspirin and ticagrelor.On (b)(6) 2020, the subject experienced cardiac insufficiency and on an unknown date the subject expired with an unknown cause of death.No action was taken to treat the event and it is unknown if an autopsy was performed.No other additional information is available at this time of report.It was further reported that, per edc, the stent was deployed without any device deficiency.
|
|
Search Alerts/Recalls
|
|